Atlas Capital Advisors’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.35K Sell
340
-67
-16% -$2.2K ﹤0.01% 900
2026
Q1
$15.2K Hold
407
﹤0.01% 775
2025
Q4
$19K Buy
+407
New +$17.6K ﹤0.01% 719
2025
Q2
$97.5K Sell
2,215
-4,790
-68% -$217K 0.01% 542
2025
Q1
$353K Buy
7,005
+6,402
+1,062% +$317K 0.04% 314
2024
Q4
$25.9K Buy
603
+216
+56% +$9.12K ﹤0.01% 694
2024
Q3
$15.2K Buy
+387
New +$14K ﹤0.01% 696
2023
Q2
Sell
-237
Closed -$11K 900
2023
Q1
$11K Hold
237
﹤0.01% 735
2022
Q4
$11K Hold
237
﹤0.01% 720
2022
Q3
$10.4K Buy
+237
New +$10.9K ﹤0.01% 714

Other funds holding G

Atlas Capital Advisors's G Position: Q2 2026 in Review

Atlas Capital Advisors reduced its Genpact (G) stake by 16% in Q2 2026, selling an estimated $2.2K and leaving 340 shares worth $9.35K. The position accounts for ﹤0.01% of the portfolio, ranked #900.

Atlas Capital Advisors first reported a position in G in Q3 2022 and has held it in 10 quarters since. The position peaked at $353K in Q1 2025. 479 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Atlas Capital Advisors held 340 shares of Genpact worth $9.35K as of Q2 2026.
  • Atlas Capital Advisors sold 67 Genpact shares in Q2 2026, an estimated $2.2K.
  • Genpact made up ﹤0.01% of Atlas Capital Advisors's portfolio in Q2 2026, its #900 holding.
  • Atlas Capital Advisors first reported a position in Genpact in Q3 2022 and has held it in 10 quarters since.
  • Atlas Capital Advisors's Genpact position peaked at $353K in Q1 2025.
  • 479 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Atlas Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.